Weight Loss

Trials such as STEP-1 and SELECT showed Wegovy not only reduced weight but also improved blood pressure, cholesterol, and markers of heart health. Other medicines, like Saxenda, also improve some metabolic measures but to a smaller extent, and drugs like Orlistat mainly affect fat absorption rather than broad cardiometabolic outcomes. Why metabolic health matters Weight management is not just about the number on the scales. Many of the health risks linked to excess weight — i

In STEP trials, people using Wegovy started to see weight changes within the first 4–8 weeks, with maximum effects building over about a...

Neither Wegovy nor Saxenda requires strict dietary rules. Both are prescribed alongside a reduced-calorie diet and increased physical...

Neither Wegovy nor Saxenda requires strict dietary rules. Both are prescribed alongside a reduced-calorie diet and increased physical...

In STEP trials, people using Wegovy started to see weight changes within the first 4–8 weeks, with maximum effects building over about a year. Ozempic, studied mainly for diabetes, also showed early improvements in blood sugar and weight within weeks, but average weight loss was smaller because of its lower doses. Early signs of progress One of the most common questions people ask is how soon results can be seen. In clinical trials of Wegovy (semaglutide 2.4 mg), participants

Wegovy contains semaglutide at a higher dose and is licensed for weight management, while Trulicity (dulaglutide) is prescribed for type...

Wegovy contains semaglutide at a higher dose and is licensed for weight management, while Trulicity (dulaglutide) is prescribed for type 2 diabetes. Weight changes with dulaglutide are usually modest compared with the significant reductions seen in trials of semaglutide for obesity. Two GLP-1 medicines, two purposes Both Wegovy and Trulicity belong to the same broad group of medicines known as GLP-1 receptor agonists. They mimic a natural hormone in the body that helps reduce

They’re not the same product: both contain semaglutide, but Wegovy is the weight-management brand (higher dose) and Ozempic is the type-2-diabetes brand (lower dose ranges). Indications, dosing schedules, and pens differ, so switching should be guided by a prescriber. Same ingredient, different goals It’s true that both Wegovy and Ozempic are based on semaglutide, a GLP-1 receptor agonist that helps regulate appetite, digestion, and blood sugar. But they were developed for di

They’re not the same product: both contain semaglutide, but Wegovy is the weight-management brand (higher dose) and Ozempic is the...

Mounjaro (tirzepatide) and Wegovy (semaglutide) are both effective; some studies show larger average weight loss with tirzepatide, but...

Mounjaro (tirzepatide) and Wegovy (semaglutide) are both effective; some studies show larger average weight loss with tirzepatide, but individual response, side-effects, access, and clinical goals matter. The “better” choice is the one that fits your health needs and tolerability after a clinician review. Two medicines, two mechanisms Wegovy and Mounjaro both belong to a family of medicines that mimic natural gut hormones involved in appetite and metabolism. Wegovy contains s

Many people report fewer intrusive food thoughts, less urgency around snacking, and improved control in situations that previously triggered overeating. That can ease emotional or stress-linked eating because the immediate pull of ultra-palatable foods is quieter. Wegovy isn’t a treatment for mental-health conditions, so ongoing support — sleep, stress tools, counselling if needed — remains important. If mood changes occur, tell your clinical team so they can review and suppo

Many people report fewer intrusive food thoughts, less urgency around snacking, and improved control in situations that previously...

Wegovy acts directly on GLP-1 receptors; effects on ghrelin and leptin are indirect and vary between individuals. By strengthening...

Wegovy acts directly on GLP-1 receptors; effects on ghrelin and leptin are indirect and vary between individuals. By strengthening...

The duration is guided by your response, tolerability, and local commissioning policy. Services typically build in review points — for...

The duration is guided by your response, tolerability, and local commissioning policy. Services typically build in review points — for example, at six months and at later milestones — to check progress and decide on continuation. Some pathways set a maximum course length; others allow ongoing use if agreed benchmarks are met within specialist care. Your team will set expectations clearly at the start so you know how and when decisions will be made. Why duration is not the sam

There isn’t a one-off loading dose; instead there’s a gradual dose-escalation (titration) phase. You start low and step up in stages...

After stopping, many people regain some weight over time because appetite signals gradually return toward baseline. How much and how...

After stopping, many people regain some weight over time because appetite signals gradually return toward baseline. How much and how quickly varies, but the pattern is common across all weight-management approaches. Planning ahead helps: keep protein intake consistent, maintain activity that preserves strength, and agree a follow-up plan with your team (for example, a slower taper, maintenance strategies, or alternative support). If you stop because goals have been met, expec